BCA
PAVM icon

Berman Capital Advisors’s PAVmed PAVM Stock Holding History

Berman Capital Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Buy
+1
New +$3.15K ﹤0.01% 1725

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Berman Capital Advisors's PAVM Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in PAVmed (PAVM) in Q3 2021: 1 share worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1725 among its holdings.

107 funds tracked by Wall St. Rank hold PAVM as of Q3 2021.

  • Berman Capital Advisors held 1 share of PAVmed worth $2K as of Q3 2021.
  • PAVmed was a new Berman Capital Advisors position in Q3 2021.
  • PAVmed made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1725 holding.
  • 107 funds tracked by Wall St. Rank held PAVmed as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.